Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $6.89 -0.30 (-4.17%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.00%, with a year-to-date return of -92.57%. In the past month, the stock has decreased 36.20%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $6.89 with a market cap of $199.71 million and volume of 143,073 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.17%1 Month Performance-36.20%3 Month Performance-40.09%Year-To-Date Performance-92.57%1 Year Performance-88.00% AVTE Stock Chart for Wednesday, August, 6, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/05/2025$6.89$6.89$7.56$6.87143,073 shs$199.71 million08/04/2025$6.89$6.89$7.56$6.87143,073 shs$199.71 million08/01/2025$6.88$7.19+4.51%$7.31$6.77143,540 shs$208.40 million07/31/2025$7.75$6.88-11.23%$7.74$6.69146,854 shs$199.42 million07/30/2025$7.75$7.75$8.33$7.74117,673 shs$224.63 million07/29/2025$8.28$7.75-6.40%$8.33$7.74117,673 shs$224.63 million07/28/2025$8.28$8.28$8.46$7.9074,574 shs$240.00 million07/25/2025$8.71$8.33-4.36%$8.71$8.29130,060 shs$241.45 million07/24/2025$8.98$8.71-3.01%$9.06$8.50123,799 shs$252.46 million07/23/2025$8.69$8.98+3.34%$9.00$8.42153,280 shs$260.29 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/22/2025$9.47$8.69-8.24%$9.57$8.55121,393 shs$251.88 million07/21/2025$9.47$9.47$9.70$9.36222,632 shs$274.49 million07/18/2025$8.81$9.51+7.95%$9.55$8.82171,880 shs$275.65 million07/17/2025$9.00$8.81-2.11%$9.07$8.49132,797 shs$255.36 million07/16/2025$9.00$9.00$10.05$8.82240,868 shs$260.87 million07/15/2025$9.82$9.00-8.35%$10.05$8.82240,868 shs$260.87 million07/14/2025$9.82$9.82$10.64$9.78154,591 shs$284.63 million07/11/2025$10.51$10.52+0.10%$10.83$10.16130,839 shs$304.92 million07/10/2025$10.45$10.51+0.57%$11.10$10.42378,549 shs$304.63 million07/09/2025$10.45$10.45$11.31$10.38275,629 shs$302.89 million07/08/2025$11.14$10.45-6.19%$11.31$10.38275,629 shs$302.89 million07/07/2025$11.14$11.14$11.33$10.14110,749 shs$322.89 million Related Companies Immunome Stock Chart Zymeworks Stock Chart Akebia Therapeutics Stock Chart Mineralys Therapeutics Stock Chart Trevi Therapeutics Stock Chart LENZ Therapeutics Stock Chart Nurix Therapeutics Stock Chart Urogen Pharma Stock Chart Nuvation Bio Stock Chart Sionna Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
